Monday, March 6, 2017 7:52 PM
|
CCSVI in Multiple Sclerosis
Putting the question out there. Shouldn't an angioplasty study look at restenosis rate and blood flow before and after treatment? Or else, why bother? “Question for IRs. If angioplasty trial doesn't look at restenosis or blood flow before/after treatment, is that a problem? #SIR17DC #CCSVI”
|